Literature DB >> 8056047

Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines.

D L Gibbons1, M Rowe, A P Cope, M Feldmann, F M Brennan.   

Abstract

A critical event in B cell immortalization by Epstein-Barr virus (EBV) is the establishment of an autocrine loop where cells produce a growth factor which supports their own proliferation. We investigated the potential of lymphoblastoid cell lines (LCL) and Burkitt lymphoma (BL) cell lines to produce and respond to the cytotoxins, tumor necrosis factor-alpha (TNF-alpha) and lymphotoxin (LT). Transformation in vitro of peripheral blood B cells by EBV from seven different donors resulted in spontaneous production of both LT (11,542 pg/ml +/- 7546, mean +/- SD) and, to a lesser extent, TNF-alpha (197 pg/ml +/- 174). Similarly BL cell lines derived from in vivo transformation which developed a 'LCL-like' phenotype in vitro (group III) produced more LT (1990 pg/ml +/- 1740) than the 'group I' BL cell lines (< 40 pg/ml LT) which had maintained the original BL biopsy cell phenotype in vitro. Transformation of peripheral blood B cells to generate LCL also resulted in an increase in surface p75 (p < 0.02) and to a lesser extent p55 (not significant, ns) TNF receptor (TNF-R) expression. Similar increases in surface TNF-R (p75 p < 0.02, p55 ns) were observed on the 'group III' BL cell lines compared with the 'group I' BL cell lines. Proliferation of an LCL and a 'group III' BL cell line in vitro was via an autocrine loop since inhibition of LT reduced proliferation. This proliferation could also be blocked in the presence of the antagonistic anti-p55 TNF-R antibody, H398, but not the antagonistic antibody anti-p75 TNF-R antibody UTR-1. Furthermore, proliferation could be induced with the p55 agonistic antibody, HTR-9. In contrast to these observations with p55 TNF-R antibodies, two out of six of the 'group III' BL lines (Jijoye and Oba) only expressed the p75 TNF-R and proliferation of these cells could only be blocked by the antagonistic anti-p75 TNF-R antibody UTR-1. These data suggest that LT is an autocrine growth factor for lymphoblastoid cells, and BL cell lines which display an LCL phenotype. Furthermore, although both TNF-R are increased on the surface of these cells, this autocrine growth signal is mediated principally through binding to the p55 TNF-R.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8056047     DOI: 10.1002/eji.1830240825

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

Review 1.  Molecular virology of Epstein-Barr virus.

Authors:  G W Bornkamm; W Hammerschmidt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

2.  Antiproliferative and proapoptotic effects of a pyrrole containing arylthioindole in human Jurkat leukemia cell line and multidrug-resistant Jurkat/A4 cells.

Authors:  Alex A Philchenkov; Michael P Zavelevich; Volodymyr P Tryndyak; Ludmila M Kuiava; Dmitry Yu Blokhin; Koh Miura; Romano Silvestri; Igor P Pogribny
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

3.  An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation.

Authors:  K M Kaye; K M Izumi; H Li; E Johannsen; D Davidson; R Longnecker; E Kieff
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

4.  Direct and indirect regulation of cytokine and cell cycle proteins by EBNA-2 during Epstein-Barr virus infection.

Authors:  L C Spender; G H Cornish; B Rowland; B Kempkes; P J Farrell
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

5.  Leukocyte adhesion in angiogenic blood vessels. Role of E-selectin, P-selectin, and beta2 integrin in lymphotoxin-mediated leukocyte recruitment in tumor microvessels.

Authors:  P Borgström; G K Hughes; P Hansell; B A Wolitsky; P Sriramarao
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

6.  Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.

Authors:  O Devergne; E Hatzivassiliou; K M Izumi; K M Kaye; M F Kleijnen; E Kieff; G Mosialos
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

Review 7.  Post-transplant lymphoproliferative disease (PTLD): lymphokine production and PTLD.

Authors:  G Tosato; J Teruya-Feldstein; J Setsuda; S E Pike; K D Jones; E S Jaffe
Journal:  Springer Semin Immunopathol       Date:  1998

Review 8.  The role of VEGF in normal and neoplastic hematopoiesis.

Authors:  Hans-Peter Gerber; Napoleone Ferrara
Journal:  J Mol Med (Berl)       Date:  2002-12-14       Impact factor: 4.599

9.  A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes.

Authors:  O Devergne; M Hummel; H Koeppen; M M Le Beau; E C Nathanson; E Kieff; M Birkenbach
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

10.  Malignant T cells express lymphotoxin α and drive endothelial activation in cutaneous T cell lymphoma.

Authors:  Britt Lauenborg; Louise Christensen; Ulrik Ralfkiaer; Katharina L Kopp; Lars Jønson; Sally Dabelsteen; Charlotte M Bonefeld; Carsten Geisler; Lise Mette R Gjerdrum; Qian Zhang; Mariusz A Wasik; Elisabeth Ralfkiaer; Niels Ødum; Anders Woetmann
Journal:  Oncotarget       Date:  2015-06-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.